Literature DB >> 32668342

Recycling of Precolectomy Anti-Tumor Necrosis Factor Agents in Chronic Pouch Inflammation Is Associated With Treatment Failure.

Maia Kayal1, Thomas Lambin2, Michael Plietz3, Anam Rizvi4, Marlana Radcliffe4, Sergey Khaitov3, Patricia Sylla3, Alexander J Greenstein3, Jean Frederic Colombel4, Marla C Dubinsky4, Ryan C Ungaro4.   

Abstract

Despite improvements in medical management, 10%-15% of patients with ulcerative colitis (UC) require total proctocolectomy (TPC) with ileal pouch anal anastomosis (IPAA) for refractory disease.1 Acute pouchitis is the most common post-IPAA inflammatory condition, with cumulative incidence of 45% at 5 years.2 Up to 20%-30% of patients develop chronic pouch inflammation (CPI), categorized as antibiotic responsive, antibiotic refractory, or Crohn's disease-like (CDL).3.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32668342     DOI: 10.1016/j.cgh.2020.07.008

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  4 in total

1.  Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology.

Authors:  Gaurav Syal; Miles P Sparrow; Fernando Velayos; Adam S Cheifetz; Shane Devlin; Peter M Irving; Gilaad G Kaplan; Laura E Raffals; Thomas Ullman; Krisztina B Gecse; Phillip R Fleshner; Amy L Lightner; Corey A Siegel; Gil Y Melmed
Journal:  Dig Dis Sci       Date:  2022-01-10       Impact factor: 3.487

2.  Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders.

Authors:  Rahul S Dalal; Sanchit Gupta; Hannah Goodrick; Jennifer Mitri; Jessica R Allegretti
Journal:  Inflamm Bowel Dis       Date:  2022-01-05       Impact factor: 7.290

Review 3.  Medical management of chronic pouch inflammation.

Authors:  Maia Kayal; Marla C Dubinsky
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-03-03

Review 4.  Medical treatment of pouchitis: a guide for the clinician.

Authors:  Wendy Rabbenou; Shannon Chang
Journal:  Therap Adv Gastroenterol       Date:  2021-06-27       Impact factor: 4.409

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.